Description

7-(2,6-Difluorophenyl)-7-Oxoheptanoic Acid is a high-purity, advanced pharmaceutical intermediate featuring a difluorophenyl ketone moiety. This compound is valued for its role as a critical building block in the synthesis of complex active pharmaceutical ingredients (APIs), particularly those targeting metabolic and inflammatory pathways. It is primarily sought by research institutions and manufacturers in the pharmaceutical and fine chemical industries for developing new therapeutic agents and proprietary compounds.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates, especially those containing fluorinated aromatic systems.
• API Synthesis: Used in the research and development of Active Pharmaceutical Ingredients (APIs) for metabolic disorders and anti-inflammatory applications.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Fine Chemical Production: Employed in the custom synthesis of complex, high-value organic molecules for specialized applications.
• Bioconjugation & Probe Development: Potential use in creating labeled compounds or probes for biochemical and diagnostic research due to its reactive carboxylic acid group.

Basic Information

Product Name	7-(2,6-Difluorophenyl)-7-Oxoheptanoic Acid
CAS No.	898766-49-9
Molecular Formula	C13H14F2O3
Molecular Weight	256.25 g/mol
Synonyms	7-Oxo-7-(2,6-difluorophenyl)heptanoic acid; 2,6-Difluoro-ω-oxobenzeneheptanoic Acid; Heptanoic acid, 7-(2,6-difluorophenyl)-7-oxo-; 7-(2,6-Difluorobenzoyl)heptanoic acid; ω-Oxo-2,6-difluorobenzeneheptanoic Acid; DFHA; 898766-49-9 (CAS)
EINECS	Contact for details

Quality Control

Our 7-(2,6-Difluorophenyl)-7-Oxoheptanoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specifications and test results. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your critical synthesis workflows.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The product should be kept under an inert atmosphere if long-term storage is required to maintain stability. Keep away from strong bases and oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Purity (HPLC, Area %)	≥ 99.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.